6 citations
,
December 2021 in “Journal of Cancer Research and Therapeutics” In this study, induction nab-paclitaxel plus cisplatin, combined with nimotuzumab and IMRT, followed by S-1 adjuvant chemotherapy, showed excellent survival benefits with tolerable toxicities for stage N3 nasopharyngeal carcinoma patients.
2 citations
,
March 2005 in “Cancer biology & therapy” This study found that 95% of untreated advanced-stage follicular lymphoma patients responded to a single course of the Bexxar regimen, with 75% achieving complete remission and remaining disease-free for years.
5 citations
,
September 1998 in “Medical hypotheses” This article discusses the potential of using flutamide and finasteride for complete androgen blockade in early-stage, low-grade prostate cancer and suggests they may improve symptom-free and overall survival compared to observation.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source notes that minoxidil and finasteride are the most supported treatments for androgenetic alopecia, with combination treatments like PRP showing promise, while the role of saw palmetto remains unclear.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study suggests that minoxidil and finasteride are the most supported treatments for androgenetic alopecia, with promising combination therapies like PRP, while saw palmetto's effectiveness remains unclear.